FOXA1 and FOXA2 not only play a key role in organ development but also participate in the reprogramming of glucose and lipid metabolism, and they are targets for preventing and treating diabetes, fatty liver, obesity, cholestasis, and cancer. This evidence concerns the gene FOXA2 and obesity disorder.